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Mutational analysis within the 39 region of the PKD1 gene. renal disease (ESRD). Other manifestations include he-
Background. Autosomal dominant polycystic kidney dis- patic cysts, cerebral aneurysms, and cardiac valve abnor-
ease (ADPKD) is one of the most common genetic diseases malities [2].in humans, affecting 1 out of 1000 individuals. At least three
At least three different genes are involved in this dis-different genes are involved in this disease. The search for
ease. PKD1 accounts for approximately 85% of ADPKDmutations in PKD1 is complicated because most of the tran-
script is encoded by a genomic region reiterated more proxi- families [3] and is localized at 16p13.3 [4, 5]. PKD2 ac-
mally on chromosome 16, and no prevalent mutation has been counts for most of the remaining cases and is localized
reported. at 4q13-23 [3, 6]. It has been proven that PKD2 is aMethods. We have screened DNA from exon 43 through
milder form of the disease [7–9]. A small number ofexon 46 and intron 40 of the PKD1 sequence by single-stranded
conformational polymorphism (SSCP) analysis in 175 ADPKD families are unlinked to the PKD1 and PKD2 loci, sug-
patients. gesting the existence of at least a third locus that remains
Results. We have found 25 differences with respect to the to be mapped [10–13].
reported PKD1 DNA sequence, seven of which are mutations
The PKD1 gene covers 52 kb of genomic DNA, con-(Q4041X, Q4124X, IVS44-1G→C, IVS45-1G→A, 12801del28,
tains 46 exons, and encodes a 14 kb mRNA. The pre-R4275W, and Q4224P). We found different phenotypical ex-
pressions of the same mutation in the families studied. We dicted protein, polycystin, is a glycoprotein with 4302
have detected several common polymorphisms, and some of amino acids. It contains 11 transmembrane domains, a
them cosegregate, suggesting a common origin of these alleles large N extracellular tail that is supposed to be involvedin PKD1.
in cell–cell or cell–matrix interactions, and a cytoplasmicConclusions. The detection of only seven mutations in 175
C termini. It contains a coiled-coil domain that interactsunrelated ADPKD patients for this region of the PKD1 ana-
lyzed suggests that mutations could be widespread throughout with PKD2. Because both proteins interact, it has been
all of the gene and that a prevalent mutation is not expected suggested that they may function through a common
to occur. The identified PKD1 missense mutations may help
signaling pathway that is necessary for normal tubulo-to refine critical regions of the protein. Until a quicker and
genesis [14–16].more sensitive method for the detection of mutations becomes
available, linkage studies will continue to be the basis for the Mutation detection in PKD1 has been hampered by
molecular diagnosis of ADPKD families. the fact that most of the PKD1 gene is reiterated more
proximally on the same chromosome and by the absence
of hot spots for mutations [17–19]. To date, 44 mutations
Autosomal dominant polycystic kidney disease have been identified in the PKD1 gene, and 16 of them
(ADPKD) is one of the most common genetic diseases are point mutations that create a premature stop codon.
in humans, affecting 1 out of 1000 individuals [1]. It is On the other hand, the studies performed by Qian et al
a multisystemic disease characterized by the progressive and Brasier and Henske show that cells isolated from
development and enlargement of multiple fluid-filled individual cysts exhibit a loss of the wild-type allele (17
cysts in the kidney that may ultimately lead to end-stage to 24% of cysts) [20, 21]. These results suggest that the
mutational mechanism in PKD1 could be due to a sec-
ond-hit mechanism in which a loss of the normal alleleKey words: ADPKD, gene mutation, SSCP analysis, inherited disease,
cysts, end-stage renal disease. in a renal epithelial cell would cause cyst formation.
We studied 175 unrelated ADPKD patients for muta-Received for publication July 9, 1998
tions in the 39 region of PKD1 (exons 43 through 46and in revised form October 15, 1998
Accepted for publication November 16, 1998 and intron 40). Twenty-five changes were detected with
respect to the reported PKD1 DNA sequence, three of 1999 by the International Society of Nephrology
1225
Badenas et al: Mutations and variants in the PKD1 gene1226
them being mutations that truncate the PKD1 protein, PR22. This is a very large four-generation family. The
ages of the different ESRD affected members are 45,two altering the normal reading frame, two being mis-
sense mutations (one of them located in the coiled-coil 56, 56, 59, and 37 years old. Two members of the family
were diagnosed with an intracranial aneurysm. Most ofdomain), and 18 corresponding to amino acid and DNA
variants. the affected members of the family are hypertensive and
were diagnosed with this condition when they were in
their 20s. All of the affected adult members of the family
METHODS
have hepatic cysts.
We screened genomic DNA from exons 43 through
46 and intron 40 of the PKD1 sequence by SSCP analysis Molecular analysis
in 90 PKD1 families (linkage analysis was performed Screening for mutation Q4041X. Polymerase chain re-
previously) [8] and 85 unrelated ADPKD individuals. action (PCR) was performed using primers 3A3C1 and
Intron 40 was studied when screening for a 51 bp deletion C2 (previously described) [5] and digested with PvuII.
in exon 40 described by Peral et al [22]. This detects the C→T transition at nucleotide 12332 de-
scribed in a previous study by Turco et al [23]. This
Clinical details
substitution results in the nonsense mutation Q4041X in
PR43. He is a 45-year-old male with bilateral polycys- exon 44 and in an additional PvuII restriction site.
tic kidneys and moderate renal impairment (serum creat- Nonradioactive single-stranded conformational poly-
inine 4.5 mg/dl). He also has hepatic cysts and was diag- morphism (SSCP) analysis. PCR reactions were per-
nosed as hypertensive at 25 years of age. His father died formed in a total volume of 25 ml containing 1 3 Boeh-
at 42 years of age because of ESRD, and his sister is 42 ringer-Mannheim PCR Buffer, 5 mm of each dNTP, 10
years old and has ADPKD and mild renal failure (serum pmol of each primer, 0.75 mm (for primers NN), and 1.5
creatinine 1.8 mg/dl). mm (for the rest) MgCl2, 1 U of Boehringer-Mannheim
PR112. The proband is a 27-year-old male who was Taq High Fidelity Polymerase, 10% DMSO, and 500
diagnosed as a newborn with polycystic kidney disease ng of DNA. The annealing temperature was 558C (for
caused by palpation of enlarged kidneys. He has also primers NN, HH, JJ, KK, and CB.3) and 608C (for the
Caroli’s disease with hepatic fibrosis. Currently, the cre- rest). The primer sequences are as follows for exon 46:
atinine level is 5 mg/dl. The sonography scan discloses CB.1 (F-tctgtgggcttcagcacttt and R-agccagcagccttagcagt);
hepatomegaly with dilation of intrahepatic bile ducts CB.2 (F-tccaccccagcagcacttag and R-gtcctggttggccacac
preferentially in the right lobe, portal cavernomatosis, agc), and CB.3 (F-gatcttcccgtggcccat and R-gtgtccactccg
splenomegaly and enlarged cystic kidneys. The father is actcca). For exon 44, they are as follows: CB.6 (F-cca
54 years old and has polycystic liver and renal disease. gtggtccgtctttgg and R-aaggcgacaccagtgagg). For exon 43,
He has been on renal replacement therapy for the last the sequences are CB.7 (F-aggtgtgcctgctgctgtt and R-cca
year. The mother and brother (24 years old) showed no cctggtcgaagctagtg). Primers HH, JJ, KK, MM, NN, PP,
evidence of ADPKD, either clinically or at ultrasound. and 3D3C1/C2 have been described previously [22].
Two uncles were diagnosed with ADPKD and started Three microliters of PCR product were combined with
renal replacement therapy at the age of 60 and 58, respec- loading buffer and were denatured and electrophoresed
tively. The grandfather and the great grandfather died in a 12% nondenaturing acrylamide for four hours at
at 58 and 50 years of age, respectively, because of uremia. 48C (500 V). The different migrations were silver stained
PR114. The proband is a 37-year-old woman who en- with the following protocol: 10% ethanol for 10 minutes,
tered ESRD at the age of 29. She was diagnosed with 1% HNO3 for three minutes, two quick rinses with dis-
hypertension at the age of 25 and has undergone a failed tilled water for 30 seconds, 0.2% AgNO3 for 20 minutes,
renal transplantation. There is no other affected member two quick rinses with distilled water, 29.6% Na2CO3/
in the family. 0.054% formaldehyde 37% for developing, and 10% ace-
PR54. This is a four-generation family with several tic acid for 10 minutes.
affected members. The affected grandmother died from Sequence analysis. PCR products were purified using
uremia at the age of 69, whereas the affected siblings the QIAquick spin PCR purification kit (Qiagen, Chats-
entered ESRD at the ages of 52, 56, and 62, respectively. worth, CA, USA) and automatically sequenced using the
All of them had hypertension and hepatic cysts. The Dye Terminator Cycle Sequencing Ready Reaction (Per-
grandchildren are 39, 40, and 41 years old, and all of kin-Elmer Cetus) and an automatic sequencer (ABI310).
them have hypertension, hepatic cysts, and normal renal
Computer analysisfunction. The 40-year-old grandchild had a subarach-
noidal hemorrhage caused by an intracranial aneurysm. The COILS2.2 program was used to study the coiled-
There is one affected member in the younger generation coil domain of polycystin in mutation Q4224P [24]. This
program predicts the structure on the basis of its similar-who has neither hypertension nor renal failure.
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Table 1. Mutations, amino acid and DNA variants 23, 25, 26], and the other five represent new mutations.
in the PKD1 gene
All but one have proved to be private mutations, found
Name Change Localization Heterozygosity only in one family of the 175 tested in this study. Six of
Mutations them are point mutations that either create a premature
Q4041X 12332C→T Exon 44 a stop codon, alter the splicing consensus sequence, or are
Q4124X 12581C→T Exon 45 a
missense mutations. The seventh mutation produces aIVS44-1G→C Intron 44 a
IVS45-1G→A Intron 45 a larger protein.
12801del28 28bp deletion Exon 46 a Nonsense mutation Q4041X. During the screening of
R4275W 13034C→T Exon 46 0.01
120 unrelated ADPKD individuals for mutation Q4041X,Q4224P 12882A→C Exon 46 a
Amino acid variants we detected one subject (PR43) with the predicted ab-
A3985G 12168C→G Exon 43 a normal heterozygous pattern. This mutation was con-
I4044V 12341A→G Exon 44 0.39
firmed by sequencing and was found in three pedigreesA4058V 12384C→T Exon 45 0.13
V4145I 12644G→A Exon 45 0.01 with different geographic origins and confirmed to arise
DNA variants independently [19]. Moreover, in patient PR43, mutation
IVS40117del14 Intron 40 0.01
Q4041X was present in the same chromosome with vari-R3970R-C/T 12124C→T Exon 43 0.03
A3991A-C/G 12184C→G Exon 43 a ants L4032L-C, V4044, and A4091A-G (Fig. 1).
L4032L-G/C 12307G→C Exon 44 a Nonsense mutation Q4124X. SSCP analysis with prim-
IVS44137ins5 Intron 44 a
ers HH in individual PR114 showed an abnormal pattern.IVS44119delG Intron 44 0.04
A4091A-A/G 12484A→G Exon 45 0.39 Sequencing revealed a C→T substitution at position 12582,
L4136L-C/T 12617C→T Exon 45 0.13 changing Glutamine 4124 to a stop codon (CAG→TAG).
P4254P-C/T 12973C→T Exon 46 a
This change creates MaeI and StyI restriction sites. This13135G→A 39UTR 0.05
13233A→G 39 UTR a mutation has also been described by Daniells et al [26].
13357T→C 39UTR a Frameshift mutation 12801del28. SSCP analysis with
13364C→T 39UTR a
primers JJ in one PKD1 patient (PR112) showed an13370G→A 39UTR a
abnormal pattern. Sequencing revealed a 28 bp not in-a Changes detected in only one chromosome of the samples studied
frame deletion. This deletion was also detected in the
proband’s son, but not in his unaffected one. The pre-
dicted abnormal protein would be 44 amino acids larger
than normal polycystin [27].ity to a database of known two-stranded coiled-coils.
Splice site mutation IVS44-1G→C. SSCP analysis us-According to program instructions, the MTIDK matrix
ing primers PP showed a heterozygous pattern in individ-was used with scanning windows of 14, 21, and 28 resi-
ual PR54. Sequencing revealed a G→C transition at thedues, and 2.5 weighting for the “a” and “d” positions
acceptor splicing site. This mutation abolishes a BbvIwas used to reduce bias toward the hydrophilic, charge-
restriction site. Family data for this patient were notrich sequences.
available.Sequence comparison of the PKD1 region, including
Splice site mutation IVS45-1G→A. SSCP analysis withmutation R4275W in human, mouse, and pufferfish (Fugu
primers MM showed an abnormal pattern in one PKD1rubripes), was performed using the BLAST, FASTA,
patient (PR22). Sequencing revealed a G→A transitionand CLUSTAL-W software programs (Internet address:
at the acceptor splicing site. Family study showed thathttp:www2.wbj.ac.uk).
IVS45-1G→A segregated with the disease. This muta-
tion abolishes a BsrI restriction site that was used to
RESULTS perform the family study.
In the screening for mutations in 175 unrelated individ- Missense mutations Q4224P and R4275W. We de-
uals, we detected 25 differences with respect to the re- tected two missense changes located in exon 46, linked
ported PKD1 DNA sequence (GDB accession numbers: to the affected chromosome, which could be considered
L33243, L43618, and L43619). Seven of them correspond as missense mutations. Q4224P is located in the coiled-
to nonsense, missense, frameshift, or splice site muta- coil domain of the PKD1 protein and abolishes a BsrI
tions. Four are amino acid variants. Six are nucleotide restriction site. This enzyme was used to screen this
substitutions that do not result in an amino acidic change. change in controls. Q4224P was not found in 365 normal
Three correspond to changes in intron sequences, and chromosomes (190 control chromosomes and 175 be-
five are located in the 39UTR. longing to the ADPKD patients; Table 2). R4275W was
found linked to the PKD1 chromosome in two unrelated
Mutations families, and in both cases, this missense change was
We identified seven mutations in the PKD1 gene (Ta- linked to four variants (A4091A-G, V4058, V4044, and
L4136L-T). Mutation R4275W abolishes a MspI restric-ble 1); two of them have been previously reported [19,
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Fig. 1. Single-strand conformational polymor-
phism (SSCP) analysis of the CB.6 polymerase
chain reaction (PCR) product corresponding to
exon 44 and intron 44 of the PKD1 gene in
patients with autosomal dominant polycystic
kidney disease (ADPKD). Abnormal fragments
correspond to L4032L-C, Q4041X, V4044,
IVS44119delG, and IVS44137ins5. PR43 pre-
sents the pattern of a normal individual plus
two extra bands representing the mutant chro-
mosome (carrying mutation Q4041X and the
L4032L-C and IVS44119delG variants). The
fact that the normal pattern is present in this
patient clearly indicates that the three detected
changes are on the same chromosome.
Table 2. Rare amino acid and DNA variants in the PKD1 gene
Change ADPKD patients Linked to PKD1 Controls Other DNA changes
Q4224P 1/175 Y 0/95
A3991A-C/G 1/175 Y 12801del28
L4032L-G/C 1/175 Y Q4041X, V4044, A4091A-G
P4254P-C/T 1/175 Y a
IVS44ins5 1/175 Y IVS45-1G→A
A3985G 1/175 N
13233A→G 1/117 Y 0/71
13370G→A 1/117 Y
13364C→T 1/117 N
13357T→C 1/117 N
R4275W 2/175 Y 0.150 A4091A-G, V4058, V4044, L4136L-T
IVS40117del14 2/95 Y/N 0/46
V4145I 3/175 U 1/173
R2970R-C/T 5/175 Y/N
The number of ADPKD patients in which the changes are detected is shown and also if they are related to the affected chromosome. Abbreviations are: Y, linked
to the PKD1 allele; N, not linked; U, only found in isolated ADPKD individuals.
a Detected in previous study [22]
tion site, and it was used to screen this mutation in 150 frequency of 0.04. IVS44137ins5 was only found in a
PKD1 family, linked to the affected chromosome andcontrols. R4274W was not found in 459 normal chromo-
somes (300 control chromosomes and 159 normal chro- to mutation IVS45-1G→A (family PR22). L4032L-C was
detected in a PKD1 patient (PR43) and linked to muta-mosomes belonging to ADPKD patients).
tion Q4041X and variants V4044 and A4091A-G (Fig.
Amino acid and DNA variants 1). R3970R-C/T was found in five unrelated patients
belonging to 175 unrelated ADPKD individuals. In threeWe identified four missense changes and 14 amino
acid variants with respect to the reported PKD1 DNA of these cases, linkage analysis was possible, and this
change was linked to the affected chromosome in onesequence (Table 1). The amino acid variants were found
in control chromosomes. A3985G was found only once family, whereas in the other two, it was linked to the
normal chromosome (Table 2).in the population studied but was linked to the normal
allele (Table 2). V4145I was found in three ADPKD Three DNA variants were relatively common: two
conserve the amino acidic sequence (L4136L-C/T andindividuals, and linkage analysis was not possible. This
change can be detected by digestion with DpnII, and it A4091A-A/G), and the third one is located in the 39UTR
(13135G→A). We detected six nucleotide substitutionswas used to screen 173 control samples, being found in
one of them. A4058V and I4044V were detected with a that were found only once in ADPKD patients and do
not alter the amino acid sequence or are located in theheterozygosity of 0.13 and 0.39, respectively.
There were 14 DNA variants detected by SSCP analy- 39UTR: A3991A-C/G, P4254P-C/T (previously described)
[22], 13370G→A, and 13233A→G were found associatedsis (Table 1). Three of them were located in introns:
IVS40117del14 was found in two PKD1 families, in one with the PKD1 chromosome, whereas 13357T→C and
13364C→T with the normal allele. Several polymor-linked to the pathogenic allele, and in the other linked
to the wild-type PKD1 gene (Table 2). IVS44119delG phisms detected in this study can be used in linkage
analysis as intragenic markers. 13135G→A has a hetero-was found in another study [18] and was observed at a
Badenas et al: Mutations and variants in the PKD1 gene 1229
Table 3. Mutations described in the PKD1 gene
Name Location Reference
Nucleotide substitutions
(missense/nonsense)
W1874X Exon 15 [29]
Q2900X Exon 23 [29]
L2993P Exon 25 [17]
Q3016R Exon 25 [17]
E3020X Exon 25 [17]
L3510V Exon 35 [17]
Q3513X Exon 35 [17]
E3631D Exon 36 [22]
M3677T Exon 38 [36]
Y3818X Exon 41 [28]
Q3837X Exon 41 [22]
Q4010X Exon 44 [18]
W4011X Exon 44 [29]
R4020X Exon 44 [33]
E4024X Exon 44 [18]
G4031D Exon 44 [18]
Q4041X Exon 44 [19, 23, this study]
Q4059X Exon 45 [26]
Fig. 2. Proposed evolution of PKD1 chromosomes carrying variants C4086X Exon 45 [32]
A4091A-A/G, A4058V, I4044V, L4136L-C/T, and 13135GA. Frequen- Q4124X Exon 45 [26, this study]
cies for these haplotypes are shown on the right. Y4126X Exon 45 [36]
Q4224P Exon 46 [This study]
R4227X Exon 46 [22]
R4275W Exon 46 [This study]
Nucleotide substitutions
zygosity of 0.05, A4058V and L4136L-C/T of 0.13, and (splicing)
IVS3911G→C Intron 39 [17]A4091A-A/G and I4044V of 0.39 in the Spanish popula-
IVS4411G→C Intron 44 [5]tion (Table 1).
IVS4421G→C Intron 44 [This study]
Five of these variants seem to be inherited together: IVS4521G→A Intron 45 [This study]
DeletionsA4091A-G and V4044 are always found in the same
4077delT Exon 15 [29]chromosomes. Whenever V4058 and L4136L-T are de-
4247del2 Exon 15 [29]
tected, the previous two are also present. If 13135G→A 5225delA Exon 15 [29]
6785del17 Exon 15 [29]is present in a chromosome, the other four variants are
IVS31125del19 Intron 31 [17]detected too. This sequence of changes led us to think
IVS39266del72 Intron 39-Exon 40 [22]
that a founder chromosome exists in which there has 8657delC Exon 23 [17]
9299delC Exon 25 [17]been an accumulation of changes (Fig. 2).
10262del2kb Introns 30–34 [5]
11457del15 Exon 39 [22]
10708del5.5kb Intron 34-Exon 46 [5]DISCUSSION
IVS43114del20 Intron 43 [37]
IVS43117del18 Intron 43 [37]Mutation detection in the PKD1 gene is complicated
12262del2 Exon 44 [18]because of the fact that it is a very large gene, with
12739delA Exon 46 [17]
all but 3.5 kb reiterated more proximally on the same 12801del28 Exon 46 [27, this study]
Insertionschromosome and a small number of mutations being
10947insT Exon 36 [22]found in more than one family. To date, only 44 muta-
11549ins10 Exon 40 [36]
tions have been identified in the PKD1 gene, most of 12416ins20 Exon 45 [26]
12511insG Exon 45 [26]them resulting in a truncated protein (Table 3 and Fig.
3). These results suggest that ADPKD may be caused
by a loss of function mechanism and that cyst formation
is the result of another mechanism inactivating the wild-
type copy of PKD1. This mechanism could explain the portions of the gene and, hence, clearly were pathogenic
changes. In addition to these mutations, two missensephenotypical variation detected in PKD1 individuals, in
which members of the same family exhibit a wide range mutations were also identified in exon 46 (Q4224P and
R4275W). Only mutation R4275W has been found inof phenotypical variation [27, 28].
We performed an SSCP analysis from exons 43 to 46 more than one family studied here, although mutations
Q4041X and Q4124X have also been reported previouslyand intron 40 in the PKD1 gene and detected seven
mutations, four amino acid variants, and 14 DNA vari- [19, 23, 26]. Moreover, mutation R4275W has been found
linked to A4091A-G, V4058, V4044, and L4136L-T sub-ants. The mutations detected in this study were mainly
frameshifting or stop mutations, eliminating significant stitutions in two unrelated families and in both cases
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Fig. 3. Map of the region of the PKD1 transcript analyzed (exons 43 through 46) showing the locations of described mutations and of the coiled-
coil domain. Mutations described in this article are shown in bold. Exons are shown in dark gray, introns in white, and the 39UTR in pale gray.
PKD1 domains as described by Sandford et al are shown at the bottom [38]: TM, transmembrane domains (white boxes) and coiled-coil domain
(filled box). Mutation 10708del5.5kb, comprising from intron 34 to exon 46, is not shown.
were linked to the affected chromosome. Because this allowing the formation of heterodimers. The coiled-coil
domain of PKD1 comprises five consecutive heptad re-missense change was detected in both families, a com-
mon ancestry could be postulated. In this and other stud- peats that have the pattern characteristic of a-helical
coiled-coil motifs (Fig. 4) [24]. Mutation Q4224P, identi-ies performed thus far, no prevalent mutation has been
found in the PKD1 gene, and most of them correspond fied in this work, is located in the position “d” of the
second heptad. The presence of a proline residue in theto private mutations. This implies that mutations in this
gene could be found anywhere in the PKD1 gene, as heptad is likely to disrupt the a-helical structure. In fact,
proline is a residue that is rarely found at any positionthree of these studies were performed in the reiterated
part of the gene, and no prevalent mutations were found of the known coiled-coil heptad repeats [24].
To check if Q4224P mutation affects the coiled-coilthere either [17, 29, 30].
Two missense mutations were identified: Q4224P and forming probability of this structure, both alleles were
analyzed with the COILS program, which predictsR4275W. Missense mutations are important to deter-
mine critical regions of the protein. It was difficult to a-helical coiled-coil domains in proteins [24]. As shown
in Figure 4, the presence of the proline residue at thedetermine whether these substitutions were pathogenic
mutations or rare polymorphisms, especially as the entire position “d” of the second heptad produces a dramatic
reduction of more than 50% in the coiled-coil formingPKD1 gene was not screened to exclude other changes.
However, in all cases in which samples were available, probability in this motif (P of wild-type allele 5 1.0, P
of mutant allele 5 0.496) when using the most stringentsegregation of the mutation with the disease was demon-
strated, and they were not found in a sizable screen of criteria (window size of 28 residues). In general, it is
assumed that residues with probabilities greater thannormal individuals. Moreover, a comparison of these
residues in other species in which the PKD1 gene has 0.5 are part of the coiled-coil segment [31]. While the
individual relative probability of the glutamine residuebeen sequenced shows that they are conserved and
Q4224P is localized in a relevant structure, the coiled- is 0.998, that of the proline residues is only 0.007. The
theoretical effect of this mutation on the motif is tocoil domain of polycystin. Qian et al identified a probable
coiled-coil structure within the C terminus of the PKD1 reduce the number of heptads identified by the COILS
program from five to the last three.gene product [15]. It is known that these domains in
other proteins may form multimeric complexes with both Although other experimental approaches will be nec-
essary to assess the effect of this change, this modelingcoiled-coil and noncoiled-coil structures. Using the yeast
two hybrid system, it was demonstrated that the coiled- study supports the hypothesis that Q4224P is a disease-
causing mutation. Other authors have reported patho-coil domain of polycystin binds specifically to the
C-terminus of the PKD2 gene product, probably through genic mutations in the PKD1 gene, because of deletions
or nonsense changes that are lacking this motif [18, 22,another coiled-coil domain present in this protein,
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Fig. 4. COILS analysis of PKD1 mutation
Q4224P. Plots showing the probability of form-
ing a coiled-coil structure (y axis, from 0 to 1)
against amino acid number (x axis, only the
carboxy termini are represented) of the wild-
type allele Q4224 and the P4224. Analyses were
performed as indicated in the Methods section
with the most stringent criteria (window size
28). The predicted coiled-coil of polycystin is
illustrated as heptad repeats of seven amino
acids. The letters a through g designate the posi-
tions of residues within the heptad with hy-
drophobic residues generally found at the “a”
and “d” positions. The five consecutive heptads
that from the coiled-coil structure are numbered
1 through 5 (residues 4214 through 4248 of poly-
cystin). The glutamine at position 4224 is boxed.
Two additional heptads (A and B), separated
from the group of five by a proline-rich block
of seven amino acids (underlined), are identified
when a smaller window size is used.
26, 29, 32, 33]. To our knowledge, this is the first case determine whether these two changes are pathogenic
mutations.described of a missense mutation within the coiled-coil
domain of polycystin. On the other hand, we have detected substitutions
A4091A-G, V4044, V4058, L4136L-T, and 13135G→AThe other missense mutation results in the substitution
of an arginine residue for a tryptophan at codon 4275, that are inherited together in some individuals, either in
the affected or the normal chromosomes. This suggestsclose to the cytoplasmic C terminus of polycystin. This
nonconservative change removes a positively charged the existence of a founder chromosome. We propose that
the sequence of changes during evolution has been theresidue and may be significant. This mutation is located
in a region of the protein in which no homology with following: A4091A-G and V4044, afterward V4058 and
L4136L-T, and finally 13135G→A (Fig. 2). As theseother proteins or motifs has been identified. However,
comparison of this residue to the PKD1 sequence from changes do not always belong to the affected chromo-
some, they imply that mutations in the PKD1 gene mayother species shows that it is highly conserved. If we
look at the corresponding sequence in mouse (GDB have arisen from different mutational events, as different
variants are linked to the affected chromosomes. Theaccession number U70209) and pufferfish (GDB accession
number AF013614), we can see a certain homology at that association of these variants with a mutation has been
reported by other authors. Rossetti et al described aregion (human amino acids 4270 to 4277, -PSRLARAS-;
mouse 4261 to 4268, -PSRLSRAS-; pufferfish 4493 to family in which mutation R4020X was linked to V4044
and V4058, but it is possible that they did not detect4500, -DSHLPRTN-). An arginine at the same position
(italicized) is conserved in the three species, indicating A4091A-G and L4136L-T [33]. Constantinides et al de-
tected that V4058 and A4091A-G were linked in 12%that substitution of this charged residue may be important.
Ultimately, a functional test for polycystin, in which of chromosomes, whereas A4091A-G was found in 15%
of chromosomes [34]. As in our study, they suggest thatmissense changes can be assayed, will be required to
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Villarroel 170, 08036 Barcelona, Spain.V4058 occurred more recently than the establishment
E-mail: rtorra@medicina.ub.es
of A4091A-G. On the other hand, they did not detect
polymorphisms V4044, L4136L-T, or 13135G→A. Wat-
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